Gefitinib
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 184475-35-2
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 110 MG | Y0001813-110-MG | In Stock | ₹ 16,085.95 |
Y0001813 - 110 MG
In Stock
Quantity
1
Base Price: ₹ 16,085.95
GST (18%): ₹ 2,895.471
Total Price: ₹ 18,981.421
grade
pharmaceutical primary standard
API family
gefitinib
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
COC(C=C(N=CN=C1NC2=CC(Cl)=C(F)C=C2)C1=C3)=C3OCCCN4CCOCC4
InChI
1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
InChI key
XGALLCVXEZPNRQ-UHFFFAOYSA-N
Gene Information
human ... EGFR(1956)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-50895 1g , Gefitinib CAS:184475-35-2 Purity:>98% | -- | ₹ 8,410.50 | ||
Cayman Chemical Gefitinib, 184475-35-2, 250 mg | -- | ₹ 7,573.90 | ||
Apexbio Technology LLC Gefitinib (ZD1839), 100mg. Cas: 184475-35-2 MFCD: MFCD04307832. Selective EGFR inhibitor | -- | ₹ 5,429.00 | ||
AdipoGen Gefitinib,Chemical. CAS: 184475-35-2 | -- | ₹ 4,663.60 | ||
eMolecules Gefitinib | 184475-35-2 | MFCD04307832 | 25g | -- | ₹ 13,755.84 | ||
AdipoGen Gefitinib,Chemical. CAS: 184475-35-2 | -- | ₹ 13,305.50 | ||
eMolecules 4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline | 184475-35-2 | MFCD04307832 | 10g | -- | ₹ 5,064.99 | ||
Selleck Chemical LLC Gefitinib (ZD1839) 100mg 184475-35-2 Iressa | -- | ₹ 21,039.60 | ||
Medchemexpress LLC HY-50895 5g , Gefitinib ZD1839 CAS:184475-35-2 Purity:98% | -- | ₹ 16,821.00 | ||
Medchemexpress LLC HY-50895 500mg Medchemexpress, Gefitinib CAS:184475-35-2 Purity:>98% | -- | ₹ 6,728.40 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Gefitinib EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P273 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 2 - Eye Dam. 1 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable